Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06939946Phase 1Terminated
Phase 1, open-label, single-arm trial, sponsored by Optosurgical. Primary endpoint: Number of Parathyroid Glands identified by the imager. Started Sep 2023; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06939946.